Joint Pain News and Research

RSS

Scientists identify specific cellular events that appear key to lupus

A team led by scientists at The Scripps Research Institute (TSRI) has identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease.

5 Feb 2013

CBT and graded exercise therapy increase likelihood of recovery from chronic fatigue syndrome

Research led by Queen Mary, University of London, has shown that recovery from chronic fatigue syndrome (CFS) is possible for some patients, and has identified two treatments most likely to lead to recovery.

2 Feb 2013

Parental depression linked to TMD pain in young adults

A mother’s depression during pregnancy is not a risk factor for temporomandibular disorders in her child, a 31-year follow-up study indicates.

21 Jan 2013

TMD pain might reflect physical manifestation of anxiety or depression

There is an ongoing debate about the role of psychological disorder symptoms as risk factors for temporomandibular joint (TMJ) pain. Previous studies have associated depression and TMJ pain but large scale studies have not been performed.

17 Jan 2013

Small numbers of ANA- and RP-negative patients with systemic sclerosis

There exists a very small subgroup of patients with systemic sclerosis who lack circulating antinuclear antibodies and who do not have Raynaud's phenomenon, research shows.

31 Dec 2012

Scientists identify molecular mechanism central to development of osteoarthritis pain

Researchers at Rush University Medical Center, in collaboration with researchers at Northwestern University, have identified a molecular mechanism central to the development of osteoarthritis (OA) pain, a finding that could have major implications for future treatment of this often-debilitating condition.

28 Dec 2012

Global travel, climate warming could create right conditions for chikungunya outbreaks in the U.S.

Global travel and climate warming could be creating the right conditions for outbreaks of a new virus in this country, according to a new Cornell University computer model.

18 Dec 2012

Iclusig gets FDA approval for two rare blood and bone marrow diseases

The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.

15 Dec 2012

Final data from Aeterna Zentaris’ perifosine plus sorafenib Phase 2 study on lymphomas

Aeterna Zentaris Inc. today announced that final Phase 2 data demonstrated that the combination of perifosine, its oral AKT inhibitor, and sorafenib, was well tolerated by heavily pretreated patients with relapsed/refractory lymphomas.

12 Dec 2012

Ibrutinib highly active and well tolerated in patients with chronic lymphocytic leukemia

Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.

11 Dec 2012

Natural product to combat menopause symptoms

Menopause is a time of great changes for most women, but information about this change of life is often sparse and contradictory. Options for symptom relief are limited. Natural products can be a healthier alternative and can provide symptom relief

10 Dec 2012

Physician's Technology launches WilloMD iLaserX device

The Italian Renaissance sculptor Michelangelo once declared "everything hurts". Baby boomers are more active than ever and stress their joints. Millions rely on dangerous pain meds and injections to stay active. Pain medication and injections can be dangerous and even lethal. Popular therapeutic pain laser technology offers hope but is not practical for home use and is out of reach of a vast patient population.

10 Dec 2012

Ibrutinib may effectively combat chronic lymphocytic leukemia

The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic lymphocytic leukemia (CLL), according to studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH).

10 Dec 2012

Guineafowl may spread Crimean-Congo hemorrhagic fever virus

Turkey raises and releases thousands of non-native guineafowl to eat ticks that carry the deadly Crimean-Congo hemorrhagic fever virus. Yet research suggests guineafowl eat few ticks, but carry the parasites on their feathers, possibly spreading the disease they were meant to stop, says a Turkish biologist working at the University of Utah.

30 Nov 2012

Two-route drug combination best for horse joint pain

A combination of systemic nonsteroidal anti-inflammatory drugs plus intrasynovial glucocorticosteroids is superior to either medication alone in improving outcomes for lame horses with perisynovial pain of the metacarpophalangeal joint, report Dutch researchers.

28 Nov 2012

UGA research finds children with noncardiac chest pain have higher levels of anxiety

Psychological factors can have as much-or more-impact on pediatric chest pain as physical ones, a University of Georgia study found recently.

17 Nov 2012

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Plexxikon today announced that updated Phase 1 clinical data of Zelboraf (vemurafenib) were presented at the Society for Melanoma Research (SMR) 2012 Congress, held November 8-11 in Los Angeles, CA.

8 Nov 2012

Roundup: Va. health chief quits, citing new abortion clinic regulations; Texas will shutter women's health program if Planned Parenthood participates

Virginia Health Commissioner Karen Remley resigned Thursday over new GOP-backed regulations that could shutter most Virginia abortion providers as reproductive rights take center stage in pivotal Senate and presidential races.

20 Oct 2012

Longer looks: The time is now for community health workers; Patients sharing in medical decisions; One doctor's plea for help

By the time Frederick Pegues Jr. was resting in bed at Temple University Hospital, the irony struck him hard. Here, he had just finished a month-long course in being a community health worker, sponsored by Temple University Hospital. He had learned how to help patients navigate a complicated health system. Yet he himself had not been able to get the help he needed.

5 Oct 2012

Hip implants are more likely to fail in obese people due to thigh size

University of Iowa researchers have determined that thigh size in obese people is a reason their hip implants are more likely to fail.

20 Sep 2012

Joint Pain News and Research

Scientists identify specific cellular events that appear key to lupus

CBT and graded exercise therapy increase likelihood of recovery from chronic fatigue syndrome

Parental depression linked to TMD pain in young adults

TMD pain might reflect physical manifestation of anxiety or depression

Small numbers of ANA- and RP-negative patients with systemic sclerosis

Scientists identify molecular mechanism central to development of osteoarthritis pain

Global travel, climate warming could create right conditions for chikungunya outbreaks in the U.S.

Iclusig gets FDA approval for two rare blood and bone marrow diseases

Final data from Aeterna Zentaris’ perifosine plus sorafenib Phase 2 study on lymphomas

Ibrutinib highly active and well tolerated in patients with chronic lymphocytic leukemia

Natural product to combat menopause symptoms

Physician's Technology launches WilloMD iLaserX device

Ibrutinib may effectively combat chronic lymphocytic leukemia

Guineafowl may spread Crimean-Congo hemorrhagic fever virus

Two-route drug combination best for horse joint pain

UGA research finds children with noncardiac chest pain have higher levels of anxiety

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Roundup: Va. health chief quits, citing new abortion clinic regulations; Texas will shutter women's health program if Planned Parenthood participates

Longer looks: The time is now for community health workers; Patients sharing in medical decisions; One doctor's plea for help

Hip implants are more likely to fail in obese people due to thigh size

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News